Primary Sclerosing Cholangitis

References

• Farrant M J, Hayllar K M, Wilkinson M L, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991; 100: 1710–7
   PubMed Web of Science ®Google Scholar
• Lindor K D, Wiesner R H, Maccarty R L, Ludwig J, Larusso N F. Advances in primary sclerosing cholangitis. Am J Med 1990; 89: 73–80
   PubMed Web of Science ®Google Scholar
• Craig D A, Maccarty R L, Wiesner R H, Grambsch P M, Larusso N F. Primary sclerosing cholangitis–value of cholangiography in determining the prognosis. Am J Roentgenol 1991; 157: 959–64
   PubMed Web of Science ®Google Scholar
• Majoie C BLM., Reeders J WAJ., Sanders J B, Huibregtse K H, Jansen P LM. Primary sclerosing cholangitis: a modified classification of cholangiographic findings. AJR 1991; 157: 495–7
   PubMed Web of Science ®Google Scholar
• Portmann B, MacSween R NM. Diseases of the intrahepatic bile ducts. Pathology of the liver, R NM MacSween, P P Anthony, P J Scheuer. Churchill Livingstone, Edinburgh 1987; 424–53
   Google Scholar
• Wiesner R H, Grambsch P M, Dickson E R, et al. Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis. Hepatology 1989; 10: 430–6
   PubMed Web of Science ®Google Scholar
• Porayko M K, Wiesner R H, Larusso N F, et al. Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology 1990; 98: 1594–602
   PubMed Web of Science ®Google Scholar
• Langnas A L, Grazi G L, Stratta R J, et al. Primary sclerosing cholangitis: the emerging role for liver transplantation. Am J Gastroenterol 1990; 85: 1136–41
   PubMed Web of Science ®Google Scholar
• Olsson R, Danielsson A, Jarnerot G, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991; 100: 1319–23
   PubMed Web of Science ®Google Scholar
• Nakanuma Y, Kono N. Expression of HLA-DR antigens on interlobular bile ducts in primary biliary cirrhosis and other hepatobiliary diseases–an immunohistochemical study. Hum Pathol 1991; 22: 431–6
   PubMed Web of Science ®Google Scholar
• Van den Oord J J, Sciot R, Desmet V J. Expression of MHC products by normal and abnormal bile duct epithelium. J Hepatol 1986; 3: 310–7
   PubMed Web of Science ®Google Scholar
• Adams D H, Hubscher S G, Shaw J, et al. Increased expression of intercellular adhesion molecular 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1991; 14: 426–31
   PubMed Web of Science ®Google Scholar
• Volpes R, Van den Oord J J, Desmet V J. Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology 1990; 12: 59–65
   PubMed Web of Science ®Google Scholar
• Kitani K, Ohta M, Kanai S. Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat. Am J Physiol 1985; 248: G407–17
   PubMedGoogle Scholar
• Chazouilleres O, Poupon R, Capron J-P, et al. Ursodeoxycholic acid for primary sclerosing cholangitis. J Hepatol 1990; 11: 120–3
   PubMed Web of Science ®Google Scholar
• Stiehl L, Rudolph G, Raedsch R, Stiehl A. Effects of ursodeoxycholic acid in patients with primary sclerosing cholangitis. Proceedings of the 58th Falk Symposium. FreiburgGermany 1990; 305–7
   Google Scholar
• Crosignani A, Podda M, Battezzati P M, et al. Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration. Hepatology 1991; 14: 1000–7
   PubMed Web of Science ®Google Scholar
• Donaldson P T, Farrant J M, Wilkinson M L, Hayllar K, Portmann B C, Williams R. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology 1991; 13: 129–33
   PubMed Web of Science ®Google Scholar
• Chapman R W, Varghese Z, Gaul R, Patel G, Kokinon N, Sherlock S. Association of primary sclerosing cholangitis with HLA-B8. Gut 1983; 24: 38–41
   PubMed Web of Science ®Google Scholar
• Prochazka E J, Terasaki P I, Park M S, Goldstein L I, Busuttil R W. Association of primary sclerosing cholangitis with HLA-DRw52A. N Engl J Med 1990; 322: 1842–4
   PubMed Web of Science ®Google Scholar
• Grunnet N, Rasmussen H H, Tage-Jensen U, Norby Rasmussen S. Association of primary sclerosing cholangitis with HLA-DRw52A. Tissue Antigens 1991; 38: 133–6
   PubMedGoogle Scholar
• Lindor K D, Wiesner R H, Larusso N F, Homburger H. Enhanced autoreactivity of T-lymphocytes in primary sclerosing cholangitis. Hepatology 1987; 7: 884–8
   PubMed Web of Science ®Google Scholar
• Senaldi G, Donaldson P T, Magrin S, et al. Activation of the complement system in primary sclerosing cholangitis. Gastroenterology 1989; 97: 1430–4
   PubMed Web of Science ®Google Scholar
• Duerr R H, Targan S R, Landers C J, et al. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991; 100: 1385–91
   PubMed Web of Science ®Google Scholar
• Knox T A, Kaplan M M. Double-blind trial of methotrexate (MTX) in the treatment of primary sclerosing cholangitis (PSC). Gastroenterology 1991; 100: A761
   Google Scholar